POLE and cholangiocarcinoma: In addition, signature 3, related to homologous recombination deficiency (4.26%), and signature 10, related to altered POLE activity (2.44%) were only identified in iCCA (Fig. 1B), which suggested that multiple types of DNA damage occurred during the carcinogenesis progress of CCA.